SCHEMBL704753

SCHEMBL704753

FC(F)Cc1cc2c[c]ccc2[nH]1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 3/20 0.33
DPP4 P27487 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2562389 0.77 RHEB (0.36) LOXL2
SCHEMBL189125 0.77 LOXL2 (0.37) LOXL2
SCHEMBL29093628 0.77 LOXL2 (0.58) LOXL2DPP4
SCHEMBL5178946 0.74 MTNR1A (0.36) LOXL2
SCHEMBL694595 0.74 ADORA1 (0.39) LOXL2
SCHEMBL9074352 0.72 LOXL2 (0.33) LOXL2
SCHEMBL1661482 0.71 SIRT1 (0.42) LOXL2
SCHEMBL5778675 0.71 RHEB (0.37) LOXL2
SCHEMBL6587779 0.71 F2 (0.51) LOXL2
SCHEMBL188218 0.70 GAA (0.35) LOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421823-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS Janssen Pharmaceutica N.V. (BE) 2012-02-29 EP claimed
WO-2010124086-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-10-28 WO claimed
EP-2421823-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS Janssen Pharmaceutica N.V. (BE) 2012-02-29 EP disclosed
WO-2010124086-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-10-28 WO disclosed